Study of Resolute Coronary Stent System in Treating Diabetic Coronary Lesions
Latest Information Update: 11 Mar 2020
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RESOLUTE-DM
- 07 Mar 2020 Results (n=62) of single-center subgroup data analysis of the RESOLUTE DM China study comparing target lesion neointima in patients with or without diabetes after zotarolimus-eluting stent treatment after 12 months follow up were published in the Advances in Therapy
- 16 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Nov 2013 Planned end date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.